BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30925534)

  • 1. Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.
    Avila-Rios S; Carlson JM; John M; Mallal S; Brumme ZL
    Curr Opin HIV AIDS; 2019 May; 14(3):194-204. PubMed ID: 30925534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.
    Kinloch NN; Lee GQ; Carlson JM; Jin SW; Brumme CJ; Byakwaga H; Muzoora C; Bwana MB; Cobarrubias KD; Hunt PW; Martin JN; Carrington M; Bangsberg DR; Harrigan PR; Brockman MA; Brumme ZL
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.
    Brumme ZL; Chopera DR; Brockman MA
    Curr Opin Virol; 2012 Oct; 2(5):599-605. PubMed ID: 22939190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective.
    Carlson JM; Brumme ZL
    Microbes Infect; 2008 Apr; 10(5):455-61. PubMed ID: 18407775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.
    Sundaramurthi JC; Swaminathan S; Hanna LE
    Immunogenetics; 2012 Oct; 64(10):767-72. PubMed ID: 22810271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.
    Frater AJ; Edwards CT; McCarthy N; Fox J; Brown H; Milicic A; Mackie N; Pillay T; Drijfhout JW; Dustan S; Clarke JR; Holmes EC; Zhang HT; Pfafferott K; Goulder PJ; McClure MO; Weber J; Phillips RE; Fidler S
    J Virol; 2006 Jul; 80(14):7226-34. PubMed ID: 16809328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
    Vinner L; Holmgren B; Jensen KJ; Esbjornsson J; Borggren M; Hentze JL; Karlsson I; Andresen BS; Gram GJ; Kloverpris H; Aaby P; Da Silva ZJ; Fenyö EM; Fomsgaard A
    APMIS; 2011 Aug; 119(8):487-97. PubMed ID: 21749448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Database-Driven Assessment of HIV-1 Adaptation to the Immune Repertoires of Human Populations.
    Karakas A; Brumme ZL; Poon AF
    J Virol; 2015 Oct; 89(20):10693-5. PubMed ID: 26246562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-mediated control of HIV and HIV adaptation to HLA.
    Payne RP; Matthews PC; Prado JG; Goulder PJ
    Adv Parasitol; 2009; 68():1-20. PubMed ID: 19289188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-adapted HIV transmission.
    Carlson JM; Du VY; Pfeifer N; Bansal A; Tan VY; Power K; Brumme CJ; Kreimer A; DeZiel CE; Fusi N; Schaefer M; Brockman MA; Gilmour J; Price MA; Kilembe W; Haubrich R; John M; Mallal S; Shapiro R; Frater J; Harrigan PR; Ndung'u T; Allen S; Heckerman D; Sidney J; Allen TM; Goulder PJ; Brumme ZL; Hunter E; Goepfert PA
    Nat Med; 2016 Jun; 22(6):606-13. PubMed ID: 27183217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.
    Leslie A; Kavanagh D; Honeyborne I; Pfafferott K; Edwards C; Pillay T; Hilton L; Thobakgale C; Ramduth D; Draenert R; Le Gall S; Luzzi G; Edwards A; Brander C; Sewell AK; Moore S; Mullins J; Moore C; Mallal S; Bhardwaj N; Yusim K; Phillips R; Klenerman P; Korber B; Kiepiela P; Walker B; Goulder P
    J Exp Med; 2005 Mar; 201(6):891-902. PubMed ID: 15781581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.
    Arora J; Pierini F; McLaren PJ; Carrington M; Fellay J; Lenz TL
    Mol Biol Evol; 2020 Mar; 37(3):639-650. PubMed ID: 31651980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
    Tumiotto C; Alves BM; Recordon-Pinson P; Jourdain M; Bellecave P; Guidicelli GL; Visentin J; Bonnet F; Hessamfar M; Neau D; Sanchez J; Brander C; Sajadi M; Eyzaguirre L; Soares EA; Routy JP; Soares MA; Fleury H
    PLoS One; 2019; 14(2):e0212347. PubMed ID: 30811489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV.
    Sundaramurthi JC; Ashokkumar M; Swaminathan S; Hanna LE
    Vaccine; 2017 Oct; 35(42):5568-5575. PubMed ID: 28888341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive evolution of HIV at HLA epitopes is associated with ethnicity in Canada.
    Ragonnet-Cronin M; Aris-Brosou S; Joanisse I; Merks H; Vallee D; Caminiti K; Sandstrom P; Brooks J
    PLoS One; 2012; 7(5):e36933. PubMed ID: 22693560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
    Bhattacharya T; Daniels M; Heckerman D; Foley B; Frahm N; Kadie C; Carlson J; Yusim K; McMahon B; Gaschen B; Mallal S; Mullins JI; Nickle DC; Herbeck J; Rousseau C; Learn GH; Miura T; Brander C; Walker B; Korber B
    Science; 2007 Mar; 315(5818):1583-6. PubMed ID: 17363674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetic surveillance of HIV/AIDS.
    Stephens HA
    Infect Genet Evol; 2012 Oct; 12(7):1481-91. PubMed ID: 22575339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.